세계의 이소류신 : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)

The global market for Isoleucine was estimated to be worth US$ 236 million in 2024 and is forecast to a readjusted size of US$ 399 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Isoleucine cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Isoleucine is an essential branched-chain amino acid (BCAA), along with leucine and valine. It plays a vital role in muscle metabolism, endurance enhancement, tissue repair, and blood sugar regulation. As the human body cannot synthesize it naturally, isoleucine must be obtained through dietary sources or supplements.

The major players in global Isoleucine market include Ajinomoto, Kyowa Hakko, Evonik, etc. The top 3 players occupy about 60% shares of the global market. China and Japan are main markets, they occupy about 60% of the global market. GMP Grade is the main type, with a share about 50%. Pharmaceutical is the main application, which holds a share about 50%.Asia (particularly China, Japan, and South Korea), North America, and Europe are the key regional markets. China has become a vital production hub with a complete industrial chain and raw material advantages.

The global isoleucine market is steadily growing, driven by:

Rising demand for sports nutrition and functional foods (particularly among fitness enthusiasts and endurance athletes)

Increasing use in medical nutrition (especially for special medical foods for liver and metabolic diseases)

Growing demand in high-grade animal feed additives (especially for pigs and poultry)

Expanding applications in the biopharmaceutical sector, especially in recombinant protein production

Market Trends:

Rising Demand for Plant-based Isoleucine: Driven by veganism and sustainability trends.

Personalized Nutrition Growth: Increasing demand for customized formulas for elderly, diabetic patients, and athletes.

Technological Innovations: Bio-fermentation and green synthesis technologies enhance purity and production efficiency.

Cross-sector Applications Expansion: Isoleucine usage is growing in biopolymers and novel functional materials beyond traditional sectors.

Competitive Landscape:

High Market Concentration: Dominated by a few large players from countries like China and Japan.

Cost Control as Key Factor: Raw material (glucose, nitrogen sources) and energy price fluctuations greatly impact producers.

Intensified Competition in Branding and Distribution: International markets demand quality certifications (ISO, HALAL, KOSHER) and stable supply chains.

Emerging Entrants Challenging Existing Order: Some new players from Europe, the US, and India are entering to disrupt the Asian monopoly.

Market Challenges:

Raw Material Price Volatility (corn, glucose) increases production cost uncertainties

Trade Barriers and Environmental Regulations intensify, especially anti-dumping cases against Chinese products in the US/EU

High Technical Barriers for Premium Applications, such as pharmaceutical-grade products requiring higher purity and safety standards

Overcapacity Risk: Especially in China, where excessive production expansion may lead to price wars

This report aims to provide a comprehensive presentation of the global market for Isoleucine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Isoleucine by region & country, by Type, and by Application.

The Isoleucine market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Isoleucine.

Market Segmentation

By Company

• Ajinomoto
• Kyowa Hakko
• Amino GmbH
• Fufeng Group
• Yichang SanXia Proudin Biopharmaceutical
• Wuxi Jinghai Amino Acid
• Meihua Group
• Jiahe Biological Technology
• Hubei Bafeng Pharmaceutical

Segment by Type

• Pharma Grade
• Food Grade
• Feed Grade

Segment by Application

• Pharmaceutical
• Sports Nutrition
• Food & Beverages
• Animal Nutrition
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Isoleucine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Isoleucine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Isoleucine in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Isoleucine Product Introduction
• 1.2 Global Isoleucine Market Size Forecast
  • 1.2.1 Global Isoleucine Sales Value (2020-2031)
  • 1.2.2 Global Isoleucine Sales Volume (2020-2031)
  • 1.2.3 Global Isoleucine Sales Price (2020-2031)
• 1.3 Isoleucine Market Trends & Drivers
  • 1.3.1 Isoleucine Industry Trends
  • 1.3.2 Isoleucine Market Drivers & Opportunity
  • 1.3.3 Isoleucine Market Challenges
  • 1.3.4 Isoleucine Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Isoleucine Players Revenue Ranking (2024)
• 2.2 Global Isoleucine Revenue by Company (2020-2025)
• 2.3 Global Isoleucine Players Sales Volume Ranking (2024)
• 2.4 Global Isoleucine Sales Volume by Company Players (2020-2025)
• 2.5 Global Isoleucine Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Isoleucine Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Isoleucine Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Isoleucine
• 2.9 Isoleucine Market Competitive Analysis
  • 2.9.1 Isoleucine Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Isoleucine Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isoleucine as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Pharma Grade
  • 3.1.2 Food Grade
  • 3.1.3 Feed Grade
• 3.2 Global Isoleucine Sales Value by Type
  • 3.2.1 Global Isoleucine Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Isoleucine Sales Value, by Type (2020-2031)
  • 3.2.3 Global Isoleucine Sales Value, by Type (%) (2020-2031)
• 3.3 Global Isoleucine Sales Volume by Type
  • 3.3.1 Global Isoleucine Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Isoleucine Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Isoleucine Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Isoleucine Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Pharmaceutical
  • 4.1.2 Sports Nutrition
  • 4.1.3 Food & Beverages
  • 4.1.4 Animal Nutrition
  • 4.1.5 Others
• 4.2 Global Isoleucine Sales Value by Application
  • 4.2.1 Global Isoleucine Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Isoleucine Sales Value, by Application (2020-2031)
  • 4.2.3 Global Isoleucine Sales Value, by Application (%) (2020-2031)
• 4.3 Global Isoleucine Sales Volume by Application
  • 4.3.1 Global Isoleucine Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Isoleucine Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Isoleucine Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Isoleucine Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Isoleucine Sales Value by Region
  • 5.1.1 Global Isoleucine Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Isoleucine Sales Value by Region (2020-2025)
  • 5.1.3 Global Isoleucine Sales Value by Region (2026-2031)
  • 5.1.4 Global Isoleucine Sales Value by Region (%), (2020-2031)
• 5.2 Global Isoleucine Sales Volume by Region
  • 5.2.1 Global Isoleucine Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Isoleucine Sales Volume by Region (2020-2025)
  • 5.2.3 Global Isoleucine Sales Volume by Region (2026-2031)
  • 5.2.4 Global Isoleucine Sales Volume by Region (%), (2020-2031)
• 5.3 Global Isoleucine Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Isoleucine Sales Value, 2020-2031
  • 5.4.2 North America Isoleucine Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Isoleucine Sales Value, 2020-2031
  • 5.5.2 Europe Isoleucine Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Isoleucine Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Isoleucine Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Isoleucine Sales Value, 2020-2031
  • 5.7.2 South America Isoleucine Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Isoleucine Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Isoleucine Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Isoleucine Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Isoleucine Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Isoleucine Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Isoleucine Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Isoleucine Sales Value, 2020-2031
  • 6.3.2 United States Isoleucine Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Isoleucine Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Isoleucine Sales Value, 2020-2031
  • 6.4.2 Europe Isoleucine Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Isoleucine Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Isoleucine Sales Value, 2020-2031
  • 6.5.2 China Isoleucine Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Isoleucine Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Isoleucine Sales Value, 2020-2031
  • 6.6.2 Japan Isoleucine Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Isoleucine Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Isoleucine Sales Value, 2020-2031
  • 6.7.2 South Korea Isoleucine Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Isoleucine Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Isoleucine Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Isoleucine Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Isoleucine Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Isoleucine Sales Value, 2020-2031
  • 6.9.2 India Isoleucine Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Isoleucine Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Ajinomoto
  • 7.1.1 Ajinomoto Company Information
  • 7.1.2 Ajinomoto Introduction and Business Overview
  • 7.1.3 Ajinomoto Isoleucine Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Ajinomoto Isoleucine Product Offerings
  • 7.1.5 Ajinomoto Recent Development
• 7.2 Kyowa Hakko
  • 7.2.1 Kyowa Hakko Company Information
  • 7.2.2 Kyowa Hakko Introduction and Business Overview
  • 7.2.3 Kyowa Hakko Isoleucine Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Kyowa Hakko Isoleucine Product Offerings
  • 7.2.5 Kyowa Hakko Recent Development
• 7.3 Amino GmbH
  • 7.3.1 Amino GmbH Company Information
  • 7.3.2 Amino GmbH Introduction and Business Overview
  • 7.3.3 Amino GmbH Isoleucine Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Amino GmbH Isoleucine Product Offerings
  • 7.3.5 Amino GmbH Recent Development
• 7.4 Fufeng Group
  • 7.4.1 Fufeng Group Company Information
  • 7.4.2 Fufeng Group Introduction and Business Overview
  • 7.4.3 Fufeng Group Isoleucine Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Fufeng Group Isoleucine Product Offerings
  • 7.4.5 Fufeng Group Recent Development
• 7.5 Yichang SanXia Proudin Biopharmaceutical
  • 7.5.1 Yichang SanXia Proudin Biopharmaceutical Company Information
  • 7.5.2 Yichang SanXia Proudin Biopharmaceutical Introduction and Business Overview
  • 7.5.3 Yichang SanXia Proudin Biopharmaceutical Isoleucine Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Yichang SanXia Proudin Biopharmaceutical Isoleucine Product Offerings
  • 7.5.5 Yichang SanXia Proudin Biopharmaceutical Recent Development
• 7.6 Wuxi Jinghai Amino Acid
  • 7.6.1 Wuxi Jinghai Amino Acid Company Information
  • 7.6.2 Wuxi Jinghai Amino Acid Introduction and Business Overview
  • 7.6.3 Wuxi Jinghai Amino Acid Isoleucine Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Wuxi Jinghai Amino Acid Isoleucine Product Offerings
  • 7.6.5 Wuxi Jinghai Amino Acid Recent Development
• 7.7 Meihua Group
  • 7.7.1 Meihua Group Company Information
  • 7.7.2 Meihua Group Introduction and Business Overview
  • 7.7.3 Meihua Group Isoleucine Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Meihua Group Isoleucine Product Offerings
  • 7.7.5 Meihua Group Recent Development
• 7.8 Jiahe Biological Technology
  • 7.8.1 Jiahe Biological Technology Company Information
  • 7.8.2 Jiahe Biological Technology Introduction and Business Overview
  • 7.8.3 Jiahe Biological Technology Isoleucine Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Jiahe Biological Technology Isoleucine Product Offerings
  • 7.8.5 Jiahe Biological Technology Recent Development
• 7.9 Hubei Bafeng Pharmaceutical
  • 7.9.1 Hubei Bafeng Pharmaceutical Company Information
  • 7.9.2 Hubei Bafeng Pharmaceutical Introduction and Business Overview
  • 7.9.3 Hubei Bafeng Pharmaceutical Isoleucine Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Hubei Bafeng Pharmaceutical Isoleucine Product Offerings
  • 7.9.5 Hubei Bafeng Pharmaceutical Recent Development

8 Industry Chain Analysis

• 8.1 Isoleucine Industrial Chain
• 8.2 Isoleucine Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Isoleucine Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Isoleucine Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer